Standard current treatment
Over the past decade, there has been much controversy about the use of HRT after the publication of the Womens Health Initiative (WHI) and Million Women studies. Recent re-analysis of the WHI data, along with results from other studies, has clarified the benefits and risks of HRT for specific populations.1 It is now known that low-dose HRT has a better safety profile when initiated within 10 years of the menopause and before the age of 60.1,2 Starting HRT around the time of the menopause may even reduce the risk of cardiovascular disease and cognitive decline.1 Starting HRT 10 or more years after the last natural period is associated with increased risks.1
Women notice an improvement in their hot flushes within four weeks of starting HRT, with maximum benefits achieved by three months.3 Oestrogen-only replacement therapy should only be used in women who have had a hysterectomy. For women who still have a uterus, oestrogen is given continuously alongside a progestogen. The progestogen can either be given sequentially (if the woman is still menstruating) or continually (if there has been 12 months or more of amenorrhoea). The addition of progestogen is vital to provide endometrial protection against the development of endometrial hyperplasia or adenocarcinoma with unopposed oestrogen use.
Progestogens can be either given orally, transdermally in a patch (in combination with oestrogen), vaginally or via an IUS. Mirena is a good option if contraception is required, if other formulations have resulted in progestogenic side-effects or if heavy bleeding is experienced with sequential HRT. Prescribing oestrogen replacement therapy with micronised progesterone, dydrogesterone or non-oral therapy is useful for women who suffer from progestogenic side-effects such as fluid retention, mastalgia, headaches and mood swings.
HRT can be administered in various forms. Usually oral treatment is prescribed first line as it is cheaper and more acceptable to women. If oral administration is not tolerated or there are relative contraindications, oestrogen patches or gels can be tried. Non-oral therapy avoids first-pass liver metabolism, thereby avoiding increased synthesis of coagulation factors, triglycerides, CRP and sex hormone binding globulin.1
There are a number of absolute contraindications to the use of HRT. They include:
Relative contraindications to the use of oral HRT include:
A meta-analysis of observational studies has shown that the risk of VTE is highest when oral oestrogen is taken and in the first year of use.4 As non-oral HRT avoids first-pass liver metabolism, transdermal HRT users have the same risk of VTE as the baseline population.5
The WHI study suggested that long-term use of HRT was associated strongly with the development of breast cancer. However, recent re-analysis of this study, along with publication of several others, provides conflicting results. There appears to be little change in the risk of breast cancer in women using oestrogen replacement therapy, and so the addition of progestogen to HRT is key to the potentiation of breast cancer cells. But overall risks remain small.
HRT should always be given at the lowest effective dose to alleviate symptoms, and for the shortest duration of time. In general, the use of HRT should be assessed on an annual basis, with the GP assessing any potential risk and the woman assessing the benefits.3 Any potential breast cancer risks of using HRT start from the age of 50. Use of HRT for less than five years after this age is unlikely to result in serious adverse effects.3 Prolonged use is acceptable, provided that women are fully informed of the potential risks.
There are various non-hormonal medications that can be prescribed for help with hot flushes, although recent NICE guidelines suggest these should not be routinely offered as a first-line treatment for vasomotor symptoms alone.5,6 Clonidine is the only non-hormonal drug with a licence for this. A meta-analysis has shown that it is slightly better than placebo at controlling flushes.2 It can be given at a dose of 50g to 100g twice daily, but is associated with nausea, dry mouth, dizziness, sedation and insomnia.3
Low-dose SSRIs and SNRIs may improve hot flushes. A study of postmenopausal women found there was a mean decrease of hot flushes by 37% in the placebo group, 62% in the group taking 12.5mg paroxetine daily, and 65% in the group taking 25mg paroxetine daily.7 Paroxetine should be started at 12.5mg and can be increased to 25mg a day, while fluoxetine should be started at 10mg and increased to 20mg a day, depending on symptom control. SSRIs are associated with nausea and decreased libido.3
The best evidence exists to support the use of venlafaxine, which should initially be started at 37.5mg daily and increased to 75mg a day if needed. Venlafaxine is associated with nausea, drowsiness, blurred vision, dry mouth and decreased libido. It should be noted that higher doses of SSRIs and SNRIs appear to be no more effective than low to moderate doses for symptom control.7
Gabapentin has also been shown to decrease hot flushes by around 50% when compared with a placebo.4 Its dose should be slowly increased by 300mg at weekly intervals to a maximum dose of 900mg a day.2 To avoid associated troublesome side-effects, such as dry mouth, drowsiness and dizziness, the patient could try taking this at night.
For women in whom oestrogen-containing HRT is contraindicated, oral progestogen can be tried. Medroxyprogesterone acetate 10mg per day may reduce flushes and sweats by 60%, but its use is off label. Norethisterone 5mg per day can also be tried. Recent studies looking at the use of HRT have suggested that the breast cancer risk may be higher in women using combined (oestrogen and progestogen) HRT compared with oestrogen replacement therapy. To date, there are no long-term data on the safety of unopposed progestogen, so it is advised to avoid the use of this in women with a history of breast cancer.
Transdermal progesterone cream has been marketed over the past 10 years or so for skeletal protection and management of menopausal symptoms. There are no data available that confirm the cream has any benefit on hot flushes, bones or the endometrium.3
Sufferers of vasomotor symptoms often find that their symptoms can be dramatically improved simply by making basic lifestyle changes. Women should wear light, natural-fibre clothing and try to sleep in a cool room. Some women find the Chillow Pillow (a personal cooling pad) and Koolabanda (a cooling scarf) useful. Both can be purchased online.
Undertaking regular exercise may decrease the incidence of hot flushes, and women should be encouraged to spend two and a half hours per week engaging in moderate aerobic activity. Smoking cessation will help with hot flushes, decrease the risk of osteoporosis and improve an individuals response to the use of HRT. Maintaining a normal body mass index of 25 or less will also help these symptoms, along with avoiding alcohol, spicy foods, hot drinks and caffeine.
Many menopausal women use complementary and alternative therapies, believing that they are safer and more natural, but there are limited data to suggest they reduce vasomotor symptoms.8 There are no long-term safety studies for herbal remedies and they may interact with other medications, particularly anticoagulants, so caution must always be exercised before use.3,5 In addition, some herbal products contain oestrogenic compounds, which may adversely affect women who have a hormone-dependent cancer.3
Red clover extracts may reduce hot flushes by 1.5 flushes per day, according to some studies.8 Black cohosh may alleviate hot flushes as well asemotional symptoms, but the Medicines and Healthcare Products Regulatory Agency has warned against its use as it is associated with liver damage.
Dietary phytoestrogens (found in soy products, nuts, legumes, oil seeds, red clover and wholegrain cereals) are related structurally to oestradiol.3 These may reduce hot flushes but can cause breast tenderness, weight gain and menstrual changes.5,8
A randomised controlled double-blinded trial that compared a daily dose of 0.625mg of conjugated equine oestrogen with phytoestrogens over a six-month period showed that phytoestrogens decrease hot flushes as effectively as oestrogen.9 There is no safety evidence available regarding the use of phytoestrogens in women with oestrogen-dependent cancers or venous thromboembolism.
There are few new products available for the treatment of hot flushes. In the near future, we may see the launch of Duavive, which combines 0.45mg conjugated equine oestrogen with 20mg bazedoxifene, a selective oestrogen receptor modulator (SERM), which protects against endometrial hyperplasia. When available, this will be licensed for the treatment of moderate to severe hot flushes and prevention of postmenopausal osteoporosis, although it may also be a useful option for women with progestogen intolerance.
Following the publication of the WHI and Million Womens studies in the early 2000s, systemic HRT prescribing fell dramatically by 66% and has remained unchanged. Previously, there was a trend to prescribe HRT in higher doses (conjugated equine oestrogen 1.25mg or 2mg oestradiol) in the belief that this would achieve better symptom control and osteoporosis prevention. It is now known that lower doses will give adequate symptom control and bone mineral density protection.
Merck, Sharp and Dohme recently stopped manufacturing and distributing oestradiol implants because only a small number of women were using this form of HRT and the company felt there were suitable alternatives. A number of women, however, found this form of HRT highly beneficial and it is therefore hoped that another manufacturer will bring a similar product onto the market in the future.
Healthcare professionals have concerns about prescribing HRT to migraine suffers with focal aura. This is because combined hormonal contraceptives have been linked with an increased risk of stroke in such women and are contraindicated. However, there are no data showing a similar risk for such women taking systemic HRT. In fact, HRT may help reduce migrainous episodes perimenopausally when hormonal fluctuations can exacerbate these headaches. In a migraine sufferer, it is preferable to use non-oral HRT rather than oralpreparations as they maintain a constant level of oestradiol and progestogen.
Dr Diana Mansour is a consultant in community gynaecology and reproductive healthcare and Dr Joanna Speedie is an ST6 trainee in community sexual and reproductive healthcare, both at Newcastle Hospitals NHS Foundation Trust.
More:
The treatment: HRT and other options for menopausal flushes - Pulse
- Bio Identical Hormone replacement therapy "alternative medicine" OMT - June 1st, 2010 [June 1st, 2010]
- Healthbeat - Hormone Replacement Therapy - August 5th, 2010 [August 5th, 2010]
- Does Hormone Replacement Therapy increase breast cancer risks? - August 11th, 2010 [August 11th, 2010]
- Hormone replacement therapy increases risk of cancer - October 20th, 2010 [October 20th, 2010]
- Hormone Replacement Therapy Risky For Women - October 20th, 2010 [October 20th, 2010]
- Can Hormone Replacement Therapy Lead To Breast Cancer? - January 31st, 2011 [January 31st, 2011]
- Women Turning To Holistic Hormone Replacement Therapy - February 18th, 2011 [February 18th, 2011]
- Is Hormone Replacement Therapy Dangerous? - March 17th, 2011 [March 17th, 2011]
- Hormone Replacement Therapy Complications - May 8th, 2011 [May 8th, 2011]
- Hormone Replacement Therapy - May 10th, 2011 [May 10th, 2011]
- The New Growth Hormone Replacement Therapy - John Crisler, DO - May 13th, 2011 [May 13th, 2011]
- Suzanne Somers on hormone therapy for menopause, part 2 of 6 - May 20th, 2011 [May 20th, 2011]
- Symptoms of Menopause (Menopause #2) - May 20th, 2011 [May 20th, 2011]
- How to Relieve Menopause Symptoms : Hormonal Replacement Therapy for Menopause - May 20th, 2011 [May 20th, 2011]
- HRT - Hormone Replacement Therapy - May 20th, 2011 [May 20th, 2011]
- What is hormone replacement therapy? - May 20th, 2011 [May 20th, 2011]
- Hormone Replacement Therapy and Breast Cancer - May 20th, 2011 [May 20th, 2011]
- Natural Treatments Instead of Hormone Replacement Therapy - May 20th, 2011 [May 20th, 2011]
- Suzanne Somers on hormone therapy for menopause, part 1 of 6 - May 23rd, 2011 [May 23rd, 2011]
- Hormone Replacement Therapy for post-menopausal women - June 19th, 2011 [June 19th, 2011]
- Joe Rogan talking about hormone replacement therapy 6-14-2011 - June 25th, 2011 [June 25th, 2011]
- Hormone Replacement Therapy and Weight - June 25th, 2011 [June 25th, 2011]
- HRC Hormone Replacement Therapy - June 25th, 2011 [June 25th, 2011]
- Study Hormone Replacement Therapy Increases Breast Cancer Risk - kdka.com - June 25th, 2011 [June 25th, 2011]
- 020 - Neo Hormones - July 1st, 2011 [July 1st, 2011]
- Making Sense of Hormone Replacement Therapy - July 28th, 2011 [July 28th, 2011]
- HRT MTF Transition Report Week 10 - July 29th, 2011 [July 29th, 2011]
- Hormone Replacement - Part 2 - July 30th, 2011 [July 30th, 2011]
- Hormone Replacement - Part 1 - July 30th, 2011 [July 30th, 2011]
- Goldie Lookin Chain - HRT - August 9th, 2011 [August 9th, 2011]
- Natural Hormone Replacement Therapy - September 23rd, 2011 [September 23rd, 2011]
- Testosterone Replacement Therapy (TRT): Optimizing Clinical Outcomes - Michael Aziz, MD - September 24th, 2011 [September 24th, 2011]
- Thyroid Replacement Therapy - Ronald Rothenberg, MD - September 24th, 2011 [September 24th, 2011]
- Dr. Ralph Turner discusses Hormone Replacement Therapy. - September 24th, 2011 [September 24th, 2011]
- 1 year on HRT - September 24th, 2011 [September 24th, 2011]
- The Wiley Protocol - September 24th, 2011 [September 24th, 2011]
- My Journal with Low Testosterone TRT Replacement Therapy - September 24th, 2011 [September 24th, 2011]
- 12 years of HRT: My Transition in photos - September 24th, 2011 [September 24th, 2011]
- Dr. Steven Jepson talks about Bio-identical Hormone Replacment Therapy - September 25th, 2011 [September 25th, 2011]
- Estradiol Valerate Injection HRT (Part 3)of(3) - September 25th, 2011 [September 25th, 2011]
- Study: Post-Menopausal Hormone Therapy Increases Cancer Risk - September 25th, 2011 [September 25th, 2011]
- Bio-identical Hormone Replacement (anti-aging) Therapy - Westchase, Tampa, Florida - September 25th, 2011 [September 25th, 2011]
- natural hormone replacement - September 28th, 2011 [September 28th, 2011]
- 6 Month Hormone Effects (before and after) - September 28th, 2011 [September 28th, 2011]
- Jeff Life, MD - Cenegenics, Hormone Replacement Therapy - September 29th, 2011 [September 29th, 2011]
- Huge - September 30th, 2011 [September 30th, 2011]
- Transsexual hormones,Intramuscular injection, Progynon Depot,Estradiol - October 2nd, 2011 [October 2nd, 2011]
- Dr Whiting on Menopause and the Dangers of HRT - October 12th, 2011 [October 12th, 2011]
- Ahuviya Harel (ADF-Fuensalida) to Start Hormone Replacement Therapy - October 13th, 2011 [October 13th, 2011]
- Clomid Defined - Video - October 14th, 2011 [October 14th, 2011]
- Thyroid Hormone Replacement Therapy - Dr. Denis Rebic - Video - October 14th, 2011 [October 14th, 2011]
- Hormone Replacement Therapy - Video - October 14th, 2011 [October 14th, 2011]
- Dr. Pamela Smith - Bio-Identical Hormone Replacement - Video - October 15th, 2011 [October 15th, 2011]
- Jasper Carrott - Traffic - October 22nd, 2011 [October 22nd, 2011]
- VIDEO: Breast Cancer, Hormone Replacement Therapy Connection - Video - October 24th, 2011 [October 24th, 2011]
- Menopause and Hormone Replacement Therapy with Dr. Sulak - Video - October 24th, 2011 [October 24th, 2011]
- Menopause - October 24th, 2011 [October 24th, 2011]
- bio identical hormone replacement therapy raleigh durcham chaepl hill north carolina - Video - October 24th, 2011 [October 24th, 2011]
- Endocrine Related Hair Loss, Can Hormone Replacement Therapy Help Treat This? Friedman - Video - October 24th, 2011 [October 24th, 2011]
- Dr. Navarro Discusses Bio Identical Hormone Replacement Therapy - Video - October 24th, 2011 [October 24th, 2011]
- Hormone Replacement Therapy by the Book - Eldred Taylor, MD - Video - October 24th, 2011 [October 24th, 2011]
- Sangeeta Pati, MD, FACOG, discusses Hormone Replacement - Video - October 24th, 2011 [October 24th, 2011]
- Active Center's Dr. Gross Discusses Bio-Identical Hormone Replacement Therapy on NEWS 12 NJ - Video - October 28th, 2011 [October 28th, 2011]
- DALLAS ANTI-AGING MEDICINE BIO-IDENTICAL HORMONE THERAPY - Video - October 29th, 2011 [October 29th, 2011]
- Hormone Replacement Therapy and Menopause in Women - Video - November 8th, 2011 [November 8th, 2011]
- Amberen - Natural HRT Alternative Commercial - Video - November 9th, 2011 [November 9th, 2011]
- The Dangers of HRT - Video - November 11th, 2011 [November 11th, 2011]
- The Benefits and Risks of Male Hormone Replacement Therapy - Video - November 16th, 2011 [November 16th, 2011]
- Natural Menopause Treatment - Herbal HRT Alternative - Video - November 23rd, 2011 [November 23rd, 2011]
- Dr. Ian Thorneycroft - Hormone Replacement Therapy - Video - November 24th, 2011 [November 24th, 2011]
- Sarah,MTF Transgender 3months HRT - Video - November 24th, 2011 [November 24th, 2011]
- 26. ftm 1 month on t - Video - November 24th, 2011 [November 24th, 2011]
- Dr. Quint Jardine - Hormone Replacement Therapy with Pellets - Video - November 24th, 2011 [November 24th, 2011]
- 6 Month Changes MTF HRT - Video - November 24th, 2011 [November 24th, 2011]
- Medical Mondays: Will hormone replacement therapy increase my risk of breast cancer? - Video - December 6th, 2011 [December 6th, 2011]
- HRT EXPERIENCES NOT ALL GOOD - Video - December 8th, 2011 [December 8th, 2011]
- Sarah, MTF transgender 9 months HRT - Video - December 9th, 2011 [December 9th, 2011]
- Full: Effect of Testosterone Replacement Therapy on Prostate Tissue in Men with Late-Onset Hypogonadism (Dramatic Health) - Video - December 10th, 2011 [December 10th, 2011]
- Suzanne Somers on hormone therapy for menopause, part 3 of 6 - Video - December 11th, 2011 [December 11th, 2011]
- 1 Year HRT MTF Transition - Video - December 12th, 2011 [December 12th, 2011]